PPM1F
Basic information
Region (hg38): 22:21919425-21952848
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPM1F gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 24 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 8 | |||||
Total | 0 | 0 | 27 | 14 | 17 |
Variants in PPM1F
This is a list of pathogenic ClinVar variants found in the PPM1F region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-21923112-G-C | Benign (Jan 16, 2024) | |||
22-21923168-G-A | not specified | Uncertain significance (Oct 26, 2024) | ||
22-21923195-T-C | not specified | Uncertain significance (Oct 25, 2024) | ||
22-21923198-A-C | Benign (Jan 29, 2024) | |||
22-21923236-C-T | Likely benign (Apr 14, 2023) | |||
22-21923264-C-T | Uncertain significance (Nov 27, 2023) | |||
22-21923289-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
22-21923294-C-T | Likely benign (Nov 13, 2023) | |||
22-21923300-C-T | not specified | Uncertain significance (Jan 06, 2023) | ||
22-21923302-G-A | Benign (Jan 22, 2024) | |||
22-21923325-G-A | not specified | Uncertain significance (Feb 17, 2023) | ||
22-21923411-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
22-21923420-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
22-21923429-G-C | Uncertain significance (May 19, 2022) | |||
22-21923433-C-T | Uncertain significance (Aug 14, 2023) | |||
22-21923440-C-G | Likely benign (Dec 21, 2023) | |||
22-21923481-C-A | Likely benign (Oct 13, 2023) | |||
22-21925556-C-T | Benign (Aug 04, 2023) | |||
22-21925585-G-T | Benign (Jan 25, 2024) | |||
22-21925592-G-A | not specified | Uncertain significance (May 25, 2022) | ||
22-21925650-G-A | Uncertain significance (Dec 28, 2021) | |||
22-21925651-C-A | Likely benign (Aug 07, 2022) | |||
22-21931130-G-T | Likely benign (Jul 28, 2023) | |||
22-21931132-G-A | Likely benign (Jun 10, 2022) | |||
22-21931141-C-A | Likely benign (Aug 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPM1F | protein_coding | protein_coding | ENST00000263212 | 7 | 33417 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00388 | 0.989 | 125723 | 0 | 13 | 125736 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 224 | 286 | 0.782 | 0.0000184 | 2908 |
Missense in Polyphen | 60 | 108.68 | 0.5521 | 1085 | ||
Synonymous | 0.989 | 113 | 127 | 0.888 | 0.00000904 | 950 |
Loss of Function | 2.34 | 7 | 17.6 | 0.398 | 8.39e-7 | 186 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000616 | 0.0000615 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000711 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Dephosphorylates and concomitantly deactivates CaM- kinase II activated upon autophosphorylation, and CaM-kinases IV and I activated upon phosphorylation by CaM-kinase kinase. Promotes apoptosis.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.652
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.15
Haploinsufficiency Scores
- pHI
- 0.947
- hipred
- Y
- hipred_score
- 0.550
- ghis
- 0.557
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppm1f
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- ppm1f
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- apoptotic
Gene ontology
- Biological process
- negative regulation of protein kinase activity;positive regulation of gene expression;positive regulation of epithelial cell migration;positive regulation of cell-substrate adhesion;histone dephosphorylation;positive regulation of cell migration;negative regulation of peptidyl-serine phosphorylation;cellular response to drug;peptidyl-threonine dephosphorylation;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;negative regulation of protein kinase activity by regulation of protein phosphorylation;negative regulation of transcription, DNA-templated;positive regulation of growth;positive regulation of chemotaxis;negative regulation of protein transport;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly;peptidyl-serine dephosphorylation;intrinsic apoptotic signaling pathway;regulation of cellular protein localization;negative regulation of cell-cell adhesion mediated by cadherin
- Cellular component
- cytosol;protein-containing complex;perinuclear region of cytoplasm
- Molecular function
- protein serine/threonine phosphatase activity;magnesium-dependent protein serine/threonine phosphatase activity;protein binding;protein tyrosine/serine/threonine phosphatase activity;calmodulin-dependent protein phosphatase activity;metal ion binding